Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods

We evaluated the prognostic role of deficient mismatch repair (dMMR) systems in stage II and stage III colon cancer patients during different postoperative periods. We also assessed whether patients aged ≥75 could benefit from chemotherapy.